Investigation Announced for Cardlytics, Inc. Shareholders
Rosen Law Firm, a worldwide leader in investor rights, is reaching out to shareholders of Cardlytics, Inc. (NASDAQ: CDLX) regarding potential securities claims. This investigation arises from allegations that the company may have provided misleading information to the investing public about its business practices.
Your Rights as an Investor
Investors who have purchased shares in Cardlytics could be eligible for compensation. Importantly, this can occur without any upfront fees thanks to a contingency fee arrangement offered by the Rosen Law Firm. This allows shareholders to seek recovery of their losses as the firm prepares a class action on behalf of affected investors.
What's Happening at Cardlytics?
Recently, Cardlytics announced results for the second quarter of the year, which highlighted a concerning 9% year-over-year decline in revenue. The Chief Financial Officer explained that while the company has seen increased activity in redemptions, challenges such as slower growth in billings and increased consumer incentives have impacted their overall results. An announcement indicated confidence in the capability to maintain investment in the business due to a robust balance sheet.
Stock Value Reaction
Following the release of these results, there was a significant market reaction. On the day after the announcement, Cardlytics stock plummeted by 57.1%, an alarming drop that has raised concerns among investors.
The Importance of Choosing the Right Legal Counsel
It is crucial for investors to choose legal counsel wisely, especially when dealing with securities class actions. The Rosen Law Firm has a storied history and extensive experience in this field, having achieved significant settlements and accolades over the years. The firm was acknowledged for recovering hundreds of millions of dollars for its clients, with a noted milestone of securing over $438 million alone in 2019.
Track Record of Success
As a top-ranked firm in terms of class action settlements, Rosen Law Firm has consistently proven its commitment to investor rights. Their founding partner was recognized among the elite in the legal field, further underscoring the firm’s expertise and track record.
Keeping Investors Informed
As this investigation unfolds, it is essential for affected investors to stay informed about their rights and options. Rosen Law Firm encourages open communication for anyone seeking assistance regarding this situation. Any shareholder interested in participating in the class action should reach out for additional information.
Contact Information for Cardlytics Issues
For inquiries regarding the class action or to discuss potential claims, shareholders can connect with representatives from Rosen Law Firm. The firm is prepared to guide investors through this process, ensuring that they understand their rights in light of these developments.
Frequently Asked Questions
What is the purpose of the Rosen Law Firm’s investigation?
The investigation seeks to uncover whether Cardlytics provided misleading information to its investors regarding its financial performance and business practices.
How does the contingency fee arrangement work?
Investors can join the class action without any upfront fees, as the firm works on a contingency basis, meaning they only get paid if the action results in compensation for the investors.
What can shareholders expect throughout the class action?
Shareholders can anticipate updates from the firm regarding the progress of the class action, alongside guidance on their rights and potential outcomes.
Why should investors choose the Rosen Law Firm?
Rosen Law Firm has a proven track record in securities class actions and has recovered substantial amounts for investors, making it a trustworthy choice for legal representation.
How can I stay up-to-date with the latest news?
Investors are encouraged to follow Rosen Law Firm on their various social media platforms for updates and relevant news regarding their rights and potential actions related to Cardlytics.
